transmation - TRNS
TRNS
Close Chg Chg %
106.78 -1.03 -0.96%
Closed Market
105.75
-1.03 (0.96%)
Volume: 96.54K
Last Updated:
Dec 20, 2024, 4:00 PM EDT
Company Overview: transmation - TRNS
TRNS Key Data
| Open $104.73 | Day Range 104.73 - 107.21 |
| 52 Week Range 94.29 - 147.12 | Market Cap $992.55M |
| Shares Outstanding 9.30M | Public Float 9.03M |
| Beta 0.70 | Rev. Per Employee N/A |
| P/E Ratio 53.83 | EPS $2.01 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 58.17K |
TRNS Performance
| 1 Week | -3.09% | ||
| 1 Month | -3.00% | ||
| 3 Months | -17.40% | ||
| 1 Year | -1.76% | ||
| 5 Years | 226.89% |
TRNS Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
5
Full Ratings ➔
About transmation - TRNS
Transcat, Inc. engages in the provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade tests, measurement, and control instrumentation. The company was founded in 1964 and is headquartered in Rochester, NY.
TRNS At a Glance
Transcat, Inc.
35 Vantage Point Drive
Rochester, New York 14624
| Phone | 1-585-352-7777 | Revenue | 259.48M | |
| Industry | Electronic Equipment/Instruments | Net Income | 13.65M | |
| Sector | Electronic Technology | 2024 Sales Growth | 12.539% | |
| Fiscal Year-end | 03 / 2025 | Employees | 1,104 | |
| View SEC Filings |
TRNS Valuation
| P/E Current | 53.826 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 68.195 |
| Price to Sales Ratio | 3.587 |
| Price to Book Ratio | 4.374 |
| Price to Cash Flow Ratio | 28.534 |
| Enterprise Value to EBITDA | 26.16 |
| Enterprise Value to Sales | 3.534 |
| Total Debt to Enterprise Value | 0.023 |
TRNS Efficiency
| Revenue/Employee | 235,037.138 |
| Income Per Employee | 12,361.413 |
| Receivables Turnover | 5.374 |
| Total Asset Turnover | 1.049 |
TRNS Liquidity
| Current Ratio | 3.139 |
| Quick Ratio | 2.619 |
| Cash Ratio | 1.05 |
TRNS Profitability
| Gross Margin | 32.298 |
| Operating Margin | 8.29 |
| Pretax Margin | 7.106 |
| Net Margin | 5.259 |
| Return on Assets | 5.517 |
| Return on Equity | 8.403 |
| Return on Total Capital | 5.532 |
| Return on Invested Capital | 6.801 |
TRNS Capital Structure
| Total Debt to Total Equity | 9.566 |
| Total Debt to Total Capital | 8.731 |
| Total Debt to Total Assets | 7.316 |
| Long-Term Debt to Equity | 7.412 |
| Long-Term Debt to Total Capital | 6.765 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Transmation - TRNS
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 173.34M | 204.96M | 230.57M | 259.48M | |
Sales Growth
| +0.14% | +18.24% | +12.50% | +12.54% | |
Cost of Goods Sold (COGS) incl D&A
| 127.22M | 146.52M | 162.21M | 175.68M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 7.58M | 9.57M | 10.96M | 13.54M | |
Depreciation
| 5.00M | 5.70M | 6.50M | 7.80M | |
Amortization of Intangibles
| 2.58M | 3.87M | 4.46M | 5.74M | |
COGS Growth
| -2.61% | +15.17% | +10.71% | +8.30% | |
Gross Income
| 46.12M | 58.44M | 68.36M | 83.81M | |
Gross Income Growth
| +8.57% | +26.72% | +16.97% | +22.60% | |
Gross Profit Margin
| +26.61% | +28.51% | +29.65% | +32.30% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 34.30M | 43.40M | 51.91M | 62.30M | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 34.30M | 43.40M | 51.91M | 62.30M | |
SGA Growth
| +8.78% | +26.54% | +19.61% | +20.01% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 850.00K | 1.00M | (200.00K) | 1.83M | |
EBIT after Unusual Expense
| 10.97M | 14.04M | 16.65M | 19.68M | |
Non Operating Income/Expense
| (141.00K) | (43.00K) | (744.00K) | 593.00K | |
Non-Operating Interest Income
| - | - | - | 808.00K | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 850.00K | 810.00K | 2.42M | 1.83M | |
Interest Expense Growth
| -8.99% | -4.71% | +198.40% | -24.08% | |
Gross Interest Expense
| 850.00K | 810.00K | 2.42M | 1.83M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 9.98M | 13.19M | 13.49M | 18.44M | |
Pretax Income Growth
| +2.59% | +32.14% | +2.25% | +36.72% | |
Pretax Margin
| +5.76% | +6.44% | +5.85% | +7.11% | |
Income Tax
| 2.19M | 1.81M | 2.80M | 4.79M | |
Income Tax - Current - Domestic
| 1.88M | 654.00K | 2.59M | 5.17M | |
Income Tax - Current - Foreign
| 103.00K | 752.00K | 395.00K | 1.19M | |
Income Tax - Deferred - Domestic
| 74.00K | 446.00K | (592.00K) | (1.13M) | |
Income Tax - Deferred - Foreign
| 137.00K | (42.00K) | 406.00K | (434.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 7.79M | 11.38M | 10.69M | 13.65M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 7.79M | 11.38M | 10.69M | 13.65M | |
Net Income Growth
| -3.42% | +46.07% | -6.08% | +27.69% | |
Net Margin Growth
| +4.49% | +5.55% | +4.64% | +5.26% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 7.79M | 11.38M | 10.69M | 13.65M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 7.79M | 11.38M | 10.69M | 13.65M | |
EPS (Basic)
| 1.0496 | 1.5181 | 1.4154 | 1.6564 | |
EPS (Basic) Growth
| -4.62% | +44.64% | -6.77% | +17.03% | |
Basic Shares Outstanding
| 7.42M | 7.50M | 7.55M | 8.24M | |
EPS (Diluted)
| 1.0322 | 1.4995 | 1.398 | 1.634 | |
EPS (Diluted) Growth
| -4.20% | +45.27% | -6.77% | +16.88% | |
Diluted Shares Outstanding
| 7.55M | 7.59M | 7.64M | 8.35M | |
EBITDA
| 19.40M | 24.61M | 27.40M | 35.05M | |
EBITDA Growth
| +10.19% | +26.84% | +11.35% | +27.92% | |
EBITDA Margin
| +11.19% | +12.01% | +11.88% | +13.51% |
Snapshot
| Average Recommendation | BUY | Average Target Price | 119.75 | |
| Number of Ratings | 5 | Current Quarters Estimate | 0.448 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 2.205 | |
| Last Quarter’s Earnings | 0.52 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.36 | Next Fiscal Year Estimate | 2.44 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | 0.45 | 0.65 | 2.21 | 2.44 |
| High Estimates | 0.57 | 0.79 | 2.55 | 2.78 |
| Low Estimate | 0.29 | 0.48 | 1.60 | 1.83 |
| Coefficient of Variance | 26.08 | 19.68 | 18.86 | 18.45 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 3 | 3 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 1 | 2 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Overweight | Overweight |
SEC Filings for Transmation - TRNS
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Transmation - TRNS
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jun 4, 2024 | James M. Jenkins Chief Legal & Corp Dev Officer | 1,854 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Jun 4, 2024 | James M. Jenkins Chief Legal & Corp Dev Officer | 1,750 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $127.73 per share | 223,527.50 |
| May 23, 2024 | Theresa A. Conroy Sr. VP, Human Resources | 783 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Theresa A. Conroy Sr. VP, Human Resources | 494 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $124.12 per share | 61,315.28 |
| May 23, 2024 | Theresa A. Conroy Sr. VP, Human Resources | 705 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Thomas L. Barbato Sr. VP Finance & CFO | 1,919 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Thomas L. Barbato Sr. VP Finance & CFO | 940 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $124.12 per share | 116,672.80 |
| May 23, 2024 | Thomas L. Barbato Sr. VP Finance & CFO | 1,376 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Scott D. Deverell | 227 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Scott D. Deverell | 2,220 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $124.12 per share | 275,546.40 |
| May 23, 2024 | Scott D. Deverell | 2,386 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Michael W. West Chief Operating Officer | 916 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Michael W. West Chief Operating Officer | 2,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Michael W. West Chief Operating Officer | 25,003 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $124.12 per share | 3,103,372.36 |
| May 23, 2024 | Michael W. West Chief Operating Officer | 25,659 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Lee D. Rudow President and CEO; Director | 3,925 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 23, 2024 | Lee D. Rudow President and CEO; Director | 103,692 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $124.12 per share | 12,870,251.04 |
| May 23, 2024 | Lee D. Rudow President and CEO; Director | 107,035 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $124.12 per share | 13,285,184.20 |
| May 23, 2024 | Lee D. Rudow President and CEO; Director | 109,028 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 15, 2024 | Charles P. Hadeed Director | 22,678 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $113 per share | 2,562,614.00 |